GrittGene Therapeutics
- Biotech or pharma, therapeutic R&D
- Diagnostics
GrittGene Therapeutics is a biotech company dedicated to curing Myotonic Dystrophy Type 2 (DM2). We are the only company with DM2 as our primary focus. Our integrated approach combines personalized regenerative stem cell therapy, full OMICS analysis (genomics, transcriptomics, proteomics, metabolomics), and advanced diagnostic tools. Through deep bioinformatics and clinical data integration, we are mapping the full biology of DM2 to uncover novel drug targets and drive small molecule discovery and repurposing
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}